Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Phase II Multi-Center, Randomized, Double-Blind, 24-Week, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD) |
|---|---|
| Disease/Condition | Mental Health and Disorders,Autism Spectrum Disorder,Pediatrics,Psychiatry - Non Cancer,Neurodevelopmental Disorders |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Eric Hollander, MD |
| Contact Name | Danya Schlussel |
| Contact Email | dschluss@montefiore.org |
| Protocol Number | 16-10-117-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Active/Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | Yes |
| Sub-Specialty | Brain and Nervous System - Autism Spectrum Disorder |
| Adult, Pediatric, Both | Pediatric |
